Indeed, it has been shown previously that tumour cell proliferation, as assessed by the Ki67 LI, was significantly higher in cases of serous ovarian cystadenocarcinoma that recurred or progressed than in those that did not (Garzetti et al, 1995). The gene discussed is MKI67; the disease is ovarian serous cystadenocarcinoma.